Management of hyperlipidemia in pediatrics

Current Opinion in Cardiology

Volumn 27, Issue 2, 2012, Pages 92-97

  Daniels, Stephen R ^a,b  

^a University of Colorado Denver and Children s Hospital Colorado   (United States)

^b CHILDREN S HOSPITAL COLORADO   (United States)

Author keywords

adolescents; children; diet; hypercholesterolemia

Indexed keywords

BILE ACID SEQUESTRANT; EZETIMIBE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL CRAMP; ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; BLOATING; CALORIC INTAKE; CARBOHYDRATE INTAKE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONSTIPATION; DRUG SAFETY; DYSLIPIDEMIA; FAT CONTENT; FOOD INTAKE; HUMAN; HYPERLIPIDEMIA; LIFESTYLE MODIFICATION; LIPID BLOOD LEVEL; MYOPATHY; MYOSITIS; OBESITY; PEDIATRICS; PHYSICAL ACTIVITY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROTEIN INTAKE; REVIEW; RHABDOMYOLYSIS; RISK FACTOR; SCREENING TEST; SIDE EFFECT; SOCIAL STATUS; TABLET; TERATOGENICITY; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

CARDIOVASCULAR DISEASES; CHILD; DISEASE MANAGEMENT; HUMANS; HYPERLIPIDEMIAS; HYPOLIPIDEMIC AGENTS; LIFE STYLE; RISK FACTORS;

EID: 84857054502     PISSN: 02684705     EISSN: 15317080     Source Type: Journal    
DOI: 10.1097/HCO.0b013e32834fea6c     Document Type: Review

References (32)

1. American Heart Association. Heart disease and stroke statistics: 2010 update. Dallas, TX: American Heart Association; 2010.
2. Berenson GS, Srinivasan SR, Bao W, et al. Association between multiple cardiovascular risk factors and the early development of atherosclerosis. Bogalusa Heart Study. N Engl J Med 1998; 338:1650-1656. (Pubitemid 28267909)
3. McGill HC Jr, McMahan CA, Malcolm GT, et al. Effects of serum lipoproteins and smoking on atherosclerosis in young men and women. The PDAY Research Group. Pathobiological Determinants of Atherosclerosis in Youth. Arterioscler Thromb Vasc Biol 1997; 17:95-106. (Pubitemid 27057330)
4. Kannel WB, Castelli WP, Gordon T, NcNamara PM. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham Study. Ann Intern Med 1971; 74:1-12.
5. Newman WP 3rd, Freedman DS, Voors AW, et al. Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis: The Bogalusa Heart Study. N Engl J Med 1986; 314:138-144. (Pubitemid 16183169)
6. Stamler J, Stamler R, Neaton JD, et al. Low-risk factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. JAMA 1999; 282:2012-2018.
7. Rose G. Sick individuals and sick populations. Int J Epidem 1985; 14:32-38. (Pubitemid 15109489)
8. Daniels SR, Greer FR, Committee on Nutrition. Lipid screening and cardiovascular health in childhood. Pediatrics 2008; 122:198-208.
9. Salo P, Viikari J, Hämä lä inen M, et al. Serum cholesterol ester fatty acids in 7- and 13-month-old children in a prospective randomized trial of a lowsaturated fat, low-cholesterol diet: the STRIP baby project. Special Turku Coronary Risk Factor Intervention Project for Children. Acta Paediatr 1999; 88:505-512. (Pubitemid 29289218)
10. Lauer RM, Lee J, Clarke WR. Predicting adult cholesterol levels from measurements in childhood and adolescence: The Muscatine Study. Bull NY Acad Med 1989; 65:1127-1142; 1154-1160. (Pubitemid 20077722)
11. Magnussen CG, Thomson R, Cleland VJ, et al. Factors affecting the stability of blood lipid and lipoprotein levels from youth to adulthood: evidence from the Childhood Determinants of Adult Health Study. Arch Pediatr Adolesc Med 2011; 165:68-76.
12. American Academy of Pediatrics. National Cholesterol Education Program: report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics 1992; 89:525-584.
13. McCrindle BW, Urbina EM, Dennison BA, et al. American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee; American Heart Association Council of Cardiovascular Disease in the Young; American Heart Association Council on Cardiovascular Nursing. Drug therapy of highrisk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation 2007; 115:1948-1967. (Pubitemid 46598908)
14. Ritchie SK, Murphy ECS, Ice C, et al. Universal versus targeted blood cholesterol screening among youth: The CARDIAC Project. Pediatrics 2010; 126:260-265.
15. Rifai N, Neufeld E, Ahlstrom P, et al. Failure of current guidelines for cholesterol screening in urban African-American adolescents. Pediatrics 1996; 98:383-388. (Pubitemid 26295838)
16. US Preventive Services Task Force. Screening for lipid disorders in children: US Preventive Services Task Force recommendation statement. Pediatrics 2007; 120l:e215-e219.
17. Daniels SR, Gidding SS, de Ferranti SD, National Lipid Association Expert Panel on Familial Hypercholesterolemia. Pediatric aspects of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol 2011; 3 Suppl:S30-S37.
18. Cui Y, Blumenthal RS, Flaws JA, et al. Nonhigh-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med 2001; 161:1413-1419. (Pubitemid 32681162)
19. Robinson JG, Wang S, Smith BJ, Jacobsen TA. Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk. J Am Coll Cardiol 2009; 53:316-322.
20. Marks D, Thorogood M, Neil HA, Humphries SE. A review on the diagnosis, natural history, and treatment of familial hypercholesterolemia. Atherosclerosis 2003; 168:1-14. (Pubitemid 36559596)
21. Kwiterovich PO Jr. State-of-the-art update and review: clinical trials of lipidlowering agents. Am J Cardiol 1998; 82:3U-17U.
22. Steinberger J, Daniels SR, Eckel RH, et al. American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition; Physical Activity, and Metabolism. Circulation 2009; 119:628-647.
23. Gidding SS, Lichtenstein AH, Faith MS, et al. Implementing American Heart Association pediatric and adult nutrition guidelines: a scientific statement from the American Heart Association Nutrition Committee of the Council on Nutrition, Physical Activity and Metabolism, Council on Cardiovascular Disease in the Young, Council on Arteriosclerosis, Thrombosis and Vascular Biology, Council on Cardiovascular Nursing, Council on Epidemiology and Prevention, and Council for High Blood Pressure Research. Circulation 2009; 119:1161-1175.
24. Lichtenstein AH, Deckelbaum RJ. American Heart Association Science Advisory. Stanol/sterol ester-containing foods and blood cholesterol levels: a statement for healthcare professionals from the Nutrition Committee of the Council on Nutrition, Physical Activity, and Metabolism of the American Heart Association. Circulation 2001; 103:1177-1179. (Pubitemid 32200197)
25. Engler MM, Engler MB, Malloy MJ, et al. Effect of docosahexanoic acid on lipoprotein subclasses in hyperlipidemic children (the EARLY study). Am J Cardiol 2005; 95:869-871. (Pubitemid 40386801)
26. Sekikawa A, Curb JD, Ueshima H, et al. for the ERA JUMP (Electronic-Beam Tomography, Risk Factor Assessment Among Japanese and U.S. Men in Post-World War II Birth Cohort) Study Group. Marine-derived n-3 fatty acids and atherosclerosis in Japanese, Japanese-American, and white men: a crosssectional study. J Am Coll Cardiol 2008; 52:417-424. (Pubitemid 352043837)
27. Strong WB, Malina RM, Blimkie CJ, et al. Evidence-based physical activity for school-age youth. J Pediatr 2005; 146:732-737. (Pubitemid 40840591)
28. Ford ES, Li C, Zhao G, Mokdad AH. Concentrations of low-density lipoprotein cholesterol and total cholesterol among children and adolescents in the United States. Circulation 2009; 119:1108-1115.
29. McCrindle BW, O'Neill MB, Cullen-Dean G, Helden E. Acceptability and compliance with two forms of cholestyramine in the treatment of hypercholesterolemia in children: a randomized, crossover trial. J Pedia r 1997; 130:266-273. (Pubitemid 27495163)
30. Stein EA, Marais AD, Szamosi T, et al. Colesevelam hydrochloride: efficacy and safety in pediatric subjects with heterozygous familial hypercholesterolemia. J Pediatr 2010; 156:231-236.
31. Waters DD. What the statin trials have taught us. Am J Cardiol 2006; 98:129-134. (Pubitemid 43902693)
32. Wiegman A, Hutten BA, de Groot E. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial. JAMA 2004; 292:331-337. (Pubitemid 38944256)